These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 24728730)
1. Is it time to validate the prognostic role of F-18-FDG PET/CT scan in thymic epithelial tumors? Lococo F; Cesario A; Treglia G Ann Nucl Med; 2014 Jul; 28(6):593-4. PubMed ID: 24728730 [No Abstract] [Full Text] [Related]
2. Reply to 'Is it time to validate the prognostic role of F-18-FDG PET/CT scan in thymic epithelial tumors?'. Chida M; Sakamoto S Ann Nucl Med; 2014 Jul; 28(6):595-6. PubMed ID: 24728731 [No Abstract] [Full Text] [Related]
3. ¹⁸F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival. Seki N; Sakamoto S; Karube Y; Oyaizu T; Ishihama H; Chida M Ann Nucl Med; 2014 Apr; 28(3):257-62. PubMed ID: 24430867 [TBL] [Abstract][Full Text] [Related]
4. Characterization of thymic lesions with F-18 FDG PET-CT: an emphasis on epithelial tumors. Liu Y Nucl Med Commun; 2011 Jul; 32(7):554-62. PubMed ID: 21403583 [TBL] [Abstract][Full Text] [Related]
5. Value of 18F-FDG PET/computed tomography in predicting the simplified WHO grade of malignancy in thymic epithelial tumors. Zhao J; Wang H; Li Q Nucl Med Commun; 2020 Apr; 41(4):405-410. PubMed ID: 32032191 [TBL] [Abstract][Full Text] [Related]
6. 18-Fluorine fluorodeoxyglucose positron emission tomography in the pretreatment evaluation of thymic epithelial neoplasms: a metabolic biopsy confirmed by Ki-67 expression. Viti A; Bertolaccini L; Cavallo A; Fortunato M; Bianchi A; Terzi A Eur J Cardiothorac Surg; 2014 Sep; 46(3):369-74; discussion 374. PubMed ID: 24585679 [TBL] [Abstract][Full Text] [Related]
8. Is (18)F-FDG PET useful in predicting the WHO grade of malignancy in thymic epithelial tumors? A meta-analysis. Treglia G; Sadeghi R; Giovanella L; Cafarotti S; Filosso P; Lococo F Lung Cancer; 2014 Oct; 86(1):5-13. PubMed ID: 25175317 [TBL] [Abstract][Full Text] [Related]
9. The utility of FDG-PET in the diagnosis of thymic epithelial tumors. Otsuka H J Med Invest; 2012; 59(3-4):225-34. PubMed ID: 23037192 [TBL] [Abstract][Full Text] [Related]
10. The role of [¹⁸F]fluorodeoxyglucose positron emission tomography in thymic epithelial tumors. Kaira K; Sunaga N; Ishizuka T; Shimizu K; Yamamoto N Cancer Imaging; 2011 Nov; 11(1):195-201. PubMed ID: 22138614 [TBL] [Abstract][Full Text] [Related]
11. Utility of 18F-fluorodeoxyglucose positron emission tomography for distinguishing between the histological types of early stage thymic epithelial tumours. Eguchi T; Yoshida K; Hamanaka K; Shiina T; Koizumi T; Kawakami S; Oguchi K; Amano J Eur J Cardiothorac Surg; 2012 May; 41(5):1059-62. PubMed ID: 22219437 [TBL] [Abstract][Full Text] [Related]
12. Differentiating the grades of thymic epithelial tumor malignancy using textural features of intratumoral heterogeneity via (18)F-FDG PET/CT. Lee HS; Oh JS; Park YS; Jang SJ; Choi IS; Ryu JS Ann Nucl Med; 2016 May; 30(4):309-19. PubMed ID: 26868139 [TBL] [Abstract][Full Text] [Related]
13. 18F-fluorodeoxyglucose positron emission tomography in the management of patients with thymic epithelial tumors. Thomas A; Mena E; Kurdziel K; Venzon D; Khozin S; Berman AW; Choyke P; Szabo E; Rajan A; Giaccone G Clin Cancer Res; 2013 Mar; 19(6):1487-93. PubMed ID: 23382114 [TBL] [Abstract][Full Text] [Related]
14. Combined imaging with 18F-FDG-PET/CT and 111In-labeled octreotide SPECT for evaluation of thymic epithelial tumors. De Luca S; Fonti R; Palmieri G; Federico P; Del Prete G; Pacelli R; Pace L; De Placido S; Salvatore M; Del Vecchio S Clin Nucl Med; 2013 May; 38(5):354-8. PubMed ID: 23486323 [TBL] [Abstract][Full Text] [Related]
15. Initial Experience of 18F-FDG PET/MRI in Thymic Epithelial Tumors: Morphologic, Functional, and Metabolic Biomarkers. Lee G; I H; Kim SJ; Pak K; Cho JS; Jeong YJ; Lee CH; Chang S Clin Nucl Med; 2016 Jan; 41(1):8-14. PubMed ID: 26284773 [TBL] [Abstract][Full Text] [Related]
16. Fluorodeoxyglucose Positron Emission Tomography Can Provide Useful Information for Differentiating Thymic Epithelial Tumors. Tomita M; Ayabe T; Tsuchiya K; Nakamura K Thorac Cardiovasc Surg; 2018 Jun; 66(4):345-349. PubMed ID: 28728209 [TBL] [Abstract][Full Text] [Related]
17. Is a positron emission tomography-computed tomography scan useful in the staging of thymic epithelial neoplasms? Viti A; Terzi A; Bianchi A; Bertolaccini L Interact Cardiovasc Thorac Surg; 2014 Jul; 19(1):129-34. PubMed ID: 24648467 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic Value of Dual-time-point F-18 FDG PET/CT and Chest CT for the Prediction of Thymic Epithelial Neoplasms. Shinya T; Tanaka T; Soh J; Matsushita T; Sato S; Toyooka S; Yoshino T; Miyoshi S; Kanazawa S Acta Med Okayama; 2017 Apr; 71(2):105-112. PubMed ID: 28420891 [TBL] [Abstract][Full Text] [Related]
19. Value of volume-based early metabolic response in patients with unresectable thymic epithelial tumor. Moon SH; Kim HS; Cho YS; Sun JM; Ahn JS; Park K; Kim BT; Ahn MJ; Lee KH Lung Cancer; 2016 Oct; 100():24-29. PubMed ID: 27597277 [TBL] [Abstract][Full Text] [Related]
20. Reply to Bertolaccini et al. Fukumoto K; Yokoi K Eur J Cardiothorac Surg; 2013 Jul; 44(1):188-9. PubMed ID: 23341042 [No Abstract] [Full Text] [Related] [Next] [New Search]